Business Development
Acusphere has developed a broad range of innovative, proprietary drug delivery technologies that include the Hydrophobic Drug Delivery System (or HDDS) and the Pulmonary Drug Delivery System (or PDDS). These technologies are described in full detail on our website in the Technology section.
Acusphere’s drug delivery technologies have resulted in three clinical development candidates: Imagify™, AI-850 and AI-128. These development candidates are described on our website in the Product Candidates section.
Acusphere has a dedicated team of scientists and engineers who offer expertise in developing custom solutions to your drug delivery needs. Our extensive experience with formulations and process development can help you manage and minimize the risks involved with bringing new drugs to the market. We are actively seeking unique partnering opportunities that can take full advantage of our proprietary technologies.
To learn more about potential partnering opportunities regarding our drug delivery technologies and licensing opportunities for any of our clinical development candidates, please contact:
Eric Huang
Associate Director, Business Development
Phone: 617-648-8828
Fax: 617-926-4750
ehuang@acusphere.com